Zobrazeno 1 - 10
of 407
pro vyhledávání: '"Jp, Henry"'
Publikováno v:
European Journal of Medicinal Chemistry. 25:369-374
The synthesis of a photosensitive iodinated derivative of tetrabenazine, which should be able to lead to the identification of the vesicular catecholamine transporter of adrenal medulla by photoaffinity, is described in detail. The biological activit
Publikováno v:
Europe PubMed Central
Autor:
Ann Henry, Nicolas Mottet, Malcolm David Mason, Thomas Wiegel, Michael Lardas, Derya Tilki, Ivo G. Schoots, Theodorus H. van der Kwast, Olivier Rouvière, Henk G. van der Poel, Silke Gillessen, Jeremy Grummet, Peter Paul M. Willemse, Nicola Fossati, Thomas Van den Broeck, Lisa Moris, Philip Cornford, Matthew Liew, Thomas B. Lam, Marcus G. Cumberbatch, Maria De Santis, Erik Briers, Roderick C.N. van den Bergh, Stefano Fanti
Publikováno v:
European Urology Focus, 6(2), 231. Elsevier BV
European Urology Focus, 6(2), 231-234. Elsevier
European Urology Focus, 6(2), 231-234. Elsevier
Biochemical recurrence (BCR) after primary treatment of localized prostate cancer does not necessarily lead to clinically apparent progressive disease. To aid in prognostication, the European Association of Urology prostate cancer guidelines panel un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0b3042d7983c70ddb19236999184fa4
https://dspace.library.uu.nl/handle/1874/394915
https://dspace.library.uu.nl/handle/1874/394915
Autor:
Maria De Santis, Suneil Jain, Nicolas Mottet, Philip Cornford, Henk G. van der Poel, Peter Paul M. Willemse, Olivier Rouvière, Theodorus H. van der Kwast, Malcolm David Mason, Muhammad Imran Omar, Raj P. Pal, Silke Gillessen, Nicola Fossati, Brian D. Kelly, Marcus G. Cumberbatch, Derya Tilki, Tanya B. Dorff, Stefano Fanti, Thomas Van den Broeck, Erik Briers, Ivo G. Schoots, Michael Lardas, Lisa Moris, Thomas Wiegel, Matthew Liew, Roderick C.N. van den Bergh, Badrinath R. Konety, Thomas B. Lam, Ann Henry, Jeremy Grummet, Cathy Yuhong Yuan, Giorgio Gandaglia
Publikováno v:
European Urology, 77(5), 614. Elsevier
Medical Biophysics Publications
European Urology, 77(5), 614-627. Elsevier
Moris, L, Cumberbatch, M G, Van den Broeck, T, Gandaglia, G, Fossati, N, Kelly, B, Pal, R, Briers, E, Cornford, P, De Santis, M, Fanti, S, Gillessen, S, Grummet, J P, Henry, A M, Lam, T B L, Lardas, M, Liew, M, Mason, M D, Omar, M I, Rouvière, O, Schoots, I G, Tilki, D, van den Bergh, R C N, van Der Kwast, T H, van Der Poel, H G, Willemse, P P M, Yuan, C Y, Konety, B, Dorff, T, Jain, S, Mottet, N & Wiegel, T 2020, ' Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review ', European Urology, vol. 77, no. 5, pp. 614-627 . https://doi.org/10.1016/j.eururo.2020.01.033
Medical Biophysics Publications
European Urology, 77(5), 614-627. Elsevier
Moris, L, Cumberbatch, M G, Van den Broeck, T, Gandaglia, G, Fossati, N, Kelly, B, Pal, R, Briers, E, Cornford, P, De Santis, M, Fanti, S, Gillessen, S, Grummet, J P, Henry, A M, Lam, T B L, Lardas, M, Liew, M, Mason, M D, Omar, M I, Rouvière, O, Schoots, I G, Tilki, D, van den Bergh, R C N, van Der Kwast, T H, van Der Poel, H G, Willemse, P P M, Yuan, C Y, Konety, B, Dorff, T, Jain, S, Mottet, N & Wiegel, T 2020, ' Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review ', European Urology, vol. 77, no. 5, pp. 614-627 . https://doi.org/10.1016/j.eururo.2020.01.033
Context: The optimal treatment for men with high-risk localized or locally advanced prostate cancer (PCa) remains unknown. Objective: To perform a systematic review of the existing literature on the effectiveness of the different primary treatment mo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07b2054a69f8c4d2527e04f5f6b92ecc
http://hdl.handle.net/11585/801920
http://hdl.handle.net/11585/801920
Autor:
Niall F. Davis, Muhammad Imran Omar, Alberto Briganti, Olivier Rouvière, James N'Dow, Ann Henry, Brett Cox, James W.F. Catto, Derya Tilki, Christopher J.D. Wallis, Maurizio Colecchia, Silke Gillessen, Steven MacLennan, Murali Varma, Thomas Van den Broeck, Philip Cornford, Susanne Vahr Lauridsen, J.P. Michiel Sedelaar, Nicola Fossati, Michael Lardas, Gemma Sancho Pardo, Paolo Dell'Oglio, André Deschamps, Nicolas Mottet, Lisa Moris, Marcus G. Cumberbatch, Thomas Wiegel, Raphaële Renard-Penna, Fabio Zattoni, James Donaldson, Phillip D. Stricker, Matthew Liew, Ivo G. Schoots, Stefano Fanti, Theodorus H. van der Kwast, Geert J.L.H. van Leenders, Nikolaos Grivas, Monique J. Roobol, Erik Briers, Hendrik Van Poppel, Karin Plass, Jeff Davies, Jonathan Richenberg, Maria De Santis, Jacques Irani, Daniel W. Lin, Shin Egawa, Tobias Gross, Peter Paul M. Willemse, Roderick C.N. van den Bergh, Alberto Bossi, Henk G. van der Poel, Chris H. Bangma, Maria J. Ribal, Giorgio Gandaglia, Alexandre Ingels, Karl H. Pang, Morgan Rouprêt, Robert Shepherd, Jeremy Grummet, Thomas B. Lam, Malcolm David Mason, Catherine Paterson, Karel Tim Buddingh, Christian D. Fankhauser, Ruud Baanders, Anders Bjartell, Philippe D. Violette, Karen Wilkinson
Publikováno v:
EUROPEAN UROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
European Urology, 76(6), 790. Elsevier
European Urology, 76(6), 790-813. Elsevier
European Urology, 76, 6, pp. 790-813
European Urology, 76, 790-813
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
European Urology, 76(6), 790. Elsevier
European Urology, 76(6), 790-813. Elsevier
European Urology, 76, 6, pp. 790-813
European Urology, 76, 790-813
Background: There is uncertainty in deferred active treatment (DAT) programmes, regarding patient selection, follow-up and monitoring, reclassification, and which outcome measures should be prioritised. Objective: To develop consensus statements for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b318ebcecc6ba380a056dacd7ce84ac8
https://dspace.library.uu.nl/handle/1874/390537
https://dspace.library.uu.nl/handle/1874/390537
Autor:
Nicola Fossati, Karel Tim Buddingh, Malcolm David Mason, Karin Plass, Christian D. Fankhauser, Steven MacLennan, Michael Lardas, James N'Dow, Henk G. van der Poel, Hendrik Van Poppel, Thomas B. Lam, Philip Cornford, Thomas Van den Broeck, Alexandre Ingels, Thomas Wiegel, Niall F. Davis, Peter-Paul M. Willemse, Catherine Paterson, Olivier Rouvière, Silke Gillessen, Lisa Moris, Fabio Zattoni, Marcus G. Cumberbatch, Matthew Liew, Theodorus H. van der Kwast, Ivo G. Schoots, Jeremy Grummet, Tobias Gross, N. Grivas, Stefano Fanti, Roderick C.N. van den Bergh, Ann Henry, Paolo Dell'Oglio, N. Mottet, James Donaldson, Muhammad Imran Omar, Derya Tilki, Maria De Santis, Erik Briers, Karl H. Pang
Publikováno v:
European Urology, 75(4), 699-702. Elsevier
Deferred active treatment (DAT) strategies, including active surveillance and active monitoring, are a recognised management option for men with localised low-risk prostate cancer. However, there is uncertainty due to heterogeneity of patient selecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54969c237dfe14a4c7c29336b816491e
https://lirias.kuleuven.be/handle/123456789/631555
https://lirias.kuleuven.be/handle/123456789/631555
Autor:
Henry JP; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Gabriel L; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Luchian ML; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Higny J; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Benoit M; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Xhaët O; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Blommaert D; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Telbis AM; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Robaye B; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Guedes A; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Demeure F; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium.
Publikováno v:
Journal of personalized medicine [J Pers Med] 2024 Oct 09; Vol. 14 (10). Date of Electronic Publication: 2024 Oct 09.
Autor:
Henry JP; Northwell, New Hyde Park, NY, USA.; Department of Orthopaedic Surgery at Huntington Hospital, Huntington, NY, USA., Partan MJ; The University of Connecticut, Farmington, CT, USA.; Department of Orthopaedic Surgery at the University of Connecticut, Farmington, CT, USA., Chen KM; Muhlenberg College, Allentown, PA, USA., Cohn RM; Northwell, New Hyde Park, NY, USA.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Garden City, NY, USA.; Department of Orthopaedic Surgery at Long Island Jewish Valley Stream, Valley Stream, NY, USA., Bitterman AD; Northwell, New Hyde Park, NY, USA.; Department of Orthopaedic Surgery at Huntington Hospital, Huntington, NY, USA.; Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Garden City, NY, USA.
Publikováno v:
Journal of osteopathic medicine [J Osteopath Med] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.
Autor:
Higny J; Department of Cardiovascular Disease, CHU UCL Namur, Yvoir, Belgium., Benoît M; Department of Cardiovascular Disease, CHU UCL Namur, Yvoir, Belgium., Henry JP; Department of Cardiovascular Disease, CHU UCL Namur, Yvoir, Belgium., Kalscheuer G; Department of Cardiac, Vascular and Thoracic Surgery, CHU UCL Namur, Yvoir, Belgium., Delaere B; Department of Infectious Diseases, CHU UCL Namur, Yvoir, Belgium., Michaux I; Department of Intensive Care Medicine, CHU UCL Namur, Yvoir, Belgium., Jamart L; Department of Cardiovascular Disease, CHRSM - Site Meuse, Namur, Belgium., Dive F; Department of Intensive Care Medicine, CHU UCL Namur, Dinant, Belgium., Luchian ML; Department of Cardiovascular Disease, CHU UCL Namur, Yvoir, Belgium.
Publikováno v:
Acta cardiologica [Acta Cardiol] 2024 Aug; Vol. 79 (6), pp. 737-738. Date of Electronic Publication: 2024 May 29.
Autor:
Henry JP; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Carlier F; Department of Pneumology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Higny J; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Benoit M; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Xhaët O; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Blommaert D; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Telbis AM; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Robaye B; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Gabriel L; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Guedes A; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Michaux I; Department of Intensive Care, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Demeure F; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium., Luchian ML; Department of Cardiology, Université Catholique de Louvain, CHU UCL Namur, 5530 Yvoir, Belgium.
Publikováno v:
Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2024 Jun 24; Vol. 14 (13). Date of Electronic Publication: 2024 Jun 24.